| |
About
Dr. Orloff, M.D., is a global R&D/business leader with nearly 25 years of experience in…
Articles by John
-
If you are at #ASH18, come visit Alexion at booth 2808 and try out our patient case study exhibit.
If you are at #ASH18, come visit Alexion at booth 2808 and try out our patient case study exhibit.
If you are at #ASH18, come visit Alexion at booth 2808 and try out our patient case study exhibit.
1 Comment
Activity
-
Today marks my 30-year anniversary with Novartis! Looking back with much gratitude, I could not have predicted where I am in my career today. My…
Today marks my 30-year anniversary with Novartis! Looking back with much gratitude, I could not have predicted where I am in my career today. My…
Liked by John Orloff
-
Orbital Therapeutics Presents Non-Human Primate Data for In Vivo CAR-T Therapy with Potential Best-in-Class Profile for Autoimmune…
Orbital Therapeutics Presents Non-Human Primate Data for In Vivo CAR-T Therapy with Potential Best-in-Class Profile for Autoimmune…
Liked by John Orloff
-
The Day I Finally Put My Uniform Away It had been hanging there for years. Perfectly pressed. Heavy starch—back in the day. My old…
The Day I Finally Put My Uniform Away It had been hanging there for years. Perfectly pressed. Heavy starch—back in the day. My old…
Liked by John Orloff
Experience & Education
-
Zenas BioPharma
View John’s full experience
See their title, tenure and more.
or
More activity by John
-
I am honored to be recognized as a member of The Wall Street Journal CCO Council, a community of leading compliance experts from some of the world’s…
I am honored to be recognized as a member of The Wall Street Journal CCO Council, a community of leading compliance experts from some of the world’s…
Liked by John Orloff
-
I am exited to announce that I started the new position as Chief Development Officer I&I at Pfizer. It is an honor to work with Michael Vincent and…
I am exited to announce that I started the new position as Chief Development Officer I&I at Pfizer. It is an honor to work with Michael Vincent and…
Liked by John Orloff
-
I’m so very proud of our Qlaris Bio, Inc. team for developing such an important addition to our pipeline. A fixed dose combination including QLS-111…
I’m so very proud of our Qlaris Bio, Inc. team for developing such an important addition to our pipeline. A fixed dose combination including QLS-111…
Liked by John Orloff
-
Excited to be appointed as a trustee at FoodCycle this month. I'm looking forward to getting started and learning more about all the great work they…
Excited to be appointed as a trustee at FoodCycle this month. I'm looking forward to getting started and learning more about all the great work they…
Liked by John Orloff
-
Please welcome Lisa von Moltke, MD, FCP as Zenas Biopharma’s Head of Research & Development and Chief Medical Officer! Dr. von Motlke's 30 years of…
Please welcome Lisa von Moltke, MD, FCP as Zenas Biopharma’s Head of Research & Development and Chief Medical Officer! Dr. von Motlke's 30 years of…
Liked by John Orloff
-
We’re honoring Autoimmune Disease Awareness Month. The Zenas team is proudly advancing multiple clinical trials for the treatment of autoimmune…
We’re honoring Autoimmune Disease Awareness Month. The Zenas team is proudly advancing multiple clinical trials for the treatment of autoimmune…
Liked by John Orloff
-
I am back from Vienna after a fantastic trip joining the European Congress of Radiology (ECR). This year, GE HealthCare showcased more than 40…
I am back from Vienna after a fantastic trip joining the European Congress of Radiology (ECR). This year, GE HealthCare showcased more than 40…
Liked by John Orloff
-
As part of our week-long celebration of #RareDiseaseDay, I had the opportunity to sit down with my colleague, @Ana Ezquerro, for our Alexion Rare…
As part of our week-long celebration of #RareDiseaseDay, I had the opportunity to sit down with my colleague, @Ana Ezquerro, for our Alexion Rare…
Liked by John Orloff
-
Excited to share that after 30 years in the pharmaceutical industry I am going on an indefinite sabbatical 🤩 I had to rethink my priorities whilst…
Excited to share that after 30 years in the pharmaceutical industry I am going on an indefinite sabbatical 🤩 I had to rethink my priorities whilst…
Liked by John Orloff
Other similar profiles
-
Kate Owen
SVP, Global Development R&D at Johnson & Johnson Innovative Medicine
Connect -
Shreeram Aradhye
Connect -
Johan Luthman
Connect -
Mathai Mammen, M.D., Ph.D.
Connect -
Troy C. Sarich, Ph.D.
Chief Commercial Data Science Officer, J&J Innovative Medicine
Connect -
Thierry Aupérin
Connect -
Javier Jimenez
Chief Medical Officer
Connect -
Staci Hargraves
Connect -
Marcus Droege
Connect -
Dash Dhanak
Connect
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top contentOthers named John Orloff in United States
-
John Orloff
-
John Orloff
Vice President at The ChemQuest Group
-
John Orloff
VP Business Development at National Adhesives
-
John Orloff
Experienced Bookselller Seeking New Career as Librarian
5 others named John Orloff in United States are on LinkedIn
See others named John Orloff